Literature DB >> 8697701

Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.

M A Bennett1, H Thurston.   

Abstract

1. This study was designed to examine the effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in Goldblatt two-kidney, one-clip hypertensive rats. Four weeks after clipping, hypertensive and sham rats were treated with either perindopril (1 mg day-1 kg-1) or quinapril (3 or 30 mg day-1 kg-1). After 6 weeks mesenteric resistance arteries were mounted in a myograph for measurements of vascular structure. The endothelium-dependent relaxation response to acetylcholine and bradykinin and the response to the nitric oxide donor sodium nitroprusside were recorded. 2. All treatment regimes lowered the blood pressure and reversed both cardiac and resistance artery hypertrophy. Two-kidney, one-clip rats treated with quinapril showed a dose-dependent reduction in media cross-sectional area and media to lumen ratio. 3. Hypertension of 10 weeks' duration was associated with an impaired endothelium-dependent relaxation response to acetylcholine and bradykinin. Treatment with perindopril and either dose of quinapril prevented the development of impaired endothelium-dependent relaxation but had no effect on the response to sodium nitroprusside. Treatment had no effect on endothelium-dependent relaxation in sham rats. 4. Angiotensin-converting enzyme inhibitor treatment is effective in normalizing blood pressure and cardiovascular structural changes. Angiotensin-converting enzyme inhibitor treatment prevented the development of impaired endothelium-dependent relaxation to both acetylcholine and bradykinin. The ability of angiotensin-converting enzyme inhibitors to reverse cardiovascular structural changes and prevent the development of abnormal endothelium-dependent relaxation may contribute to the overall effect of this type of antihypertensive drug.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697701     DOI: 10.1042/cs0900021

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

1.  Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats.

Authors:  D Rousseau; C Héliès-Toussaint; D Raederstorff; D Moreau; A Grynberg
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

2.  Effects of chronic quercetin treatment in experimental renovascular hypertension.

Authors:  María Francisca García-Saura; Milagros Galisteo; Inmaculada Concepción Villar; Almudena Bermejo; Antonio Zarzuelo; Félix Vargas; Juan Duarte
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Endothelial dysfunction: Possible mechanisms and ways of correction.

Authors:  Vadim Sagach; Alexander Bondarenko; Olga Bazilyuk; Anatoliy Kotsuruba
Journal:  Exp Clin Cardiol       Date:  2006

4.  Hemodynamic and neural responses to renal denervation of the nerve to the clipped kidney by cryoablation in two-kidney, one-clip hypertensive rats.

Authors:  Noreen F Rossi; Russell Pajewski; Haiping Chen; Peter J Littrup; Maria Maliszewska-Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-18       Impact factor: 3.619

5.  Quinapril effects on resistance artery structure and function in hypertension.

Authors:  Lufang Yang; Yu-Jing Gao; Robert M K W Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-10       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.